BAY43-9006
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY43-9006, covering 2013-11-13 to 2013-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) [Phase 1]